Lymphoma: October 2006 Archives

Cancer patients desperate for options


herbal treatmentGREENWOOD, Miss. -- Abraham Cherrix never set out to be an advocate for alternative medicine. He is just a 16-year-old with cancer who refused to undergo a second round of chemotherapy and went to court to fight for his right not to have it.

In a court-ordered compromise, the Virginia teenager landed at the North Central Mississippi Regional Cancer Center, one of a new breed of cancer facilities in the United States that integrate conventional medicine and alternative therapies.

Cherrix's struggle to use herbs and diet supplements to fight Hodgkin's disease, a cancer of the lymphatic system--rather than have a series of debilitating rounds of chemotherapy--has brought attention to a growing movement in the U.S. to bring alternative medicine into the mainstream.

Bright idea of sticky plaster that can beat skin cancer


Ifor Samuel (courtesy of scientists have invented a light-emitting "sticking plaster" for treating skin cancer which could revolutionise the way the disease is treated.

The high-tech patch is operated by a pocket-sized battery and could allow patients to receive treatment at home or at a GP surgery instead of undergoing lengthy hospital visits.

Current skin cancer treatment can involve surgical removal of lesions, with associated scarring and risk of infection.

Skin treatment targets cancer and acne


skin cancer cellsThere's news for your health about a high-tech skin treatment that targets two very different conditions. It's called photodynamic therapy.

Not only does it clear up severe acne, it can also stop certain types of skin cancer in the earliest stages.

"About 10-years ago I started to develop skin cancers on my body and I've had about four or five removed." It's the price Debby Robinson pays for having spent so much time in the sun over the years.

And this could be just the beginning.

A type of Non-Hodgkin's lymphoma (NHL) called mantle cell lymphoma accounts for about five to ten percent of all lymphomas. According to an article recently published in the Journal of Clinical Oncology, Velcade (bortezobib) is an effective treatment option for patients with mantle cell lymphoma that has stopped responding to prior treatments.

Beachgoers Accurately Report Sun-Protection Habits


FRIDAY, Oct. 20 (HealthDay News) -- Skin cancer researchers focused on sun exposure may be on the right track: A new study finds that beachgoers accurately report their sun habits, such as use of sunscreen, protective clothing and time spent in the sun.

A team from the University of Hawaii, Honolulu, studied 88 adults, average age 40, who visited a beach in Honolulu in February or March 2004. The participants answered questions about their sun habits when they arrived at the beach, and again when they left the beach.

The researchers checked the participants' arms, legs and face for sunscreen, took note of their clothing, and assessed whether they had a sunburn.

Listening to the sound of skin cancer


WASHINGTON, Oct. 16 -- Researchers at the University of Missouri-Columbia can now detect the spread of skin cancer cells through the blood by literally listening to their sound. The unprecedented, minimally invasive technique causes melanoma cells to emit noise, and could let oncologists spot early signs of metastases -- as few as 10 cancer cells in a blood sample -- before they even settle in other organs. The results of the successful experimental tests appear in the Oct. 15 issue of the journal Optics Letters, published by the Optical Society of America.

The team's method, called photoacoustic detection, combines laser techniques from optics and ultrasound techniques from acoustics, using a laser to make cells vibrate and then picking up the characteristic sound of melanoma cells. In a clinical test, doctors would take a patient's blood sample and separate the red blood cells and the plasma. In a healthy person, the remaining cells would be white blood cells, but in a melanoma patient the sample may contain cancer cells. To find out, doctors would put the sample in saline solution and expose it to rapid-fire sequences of brief but intense blue-laser pulses, each lasting just five billionths of a second.

Red Hair gene linked to skin cancer


NEW YORK, REUTERS - Genes involved in skin pigmentation have an effect on a person’s skin cancer risk beyond their influence on a person’s hair or skin color, a new study shows.

Women who carried one so-called “red hair color” gene but had medium or olive skin, as opposed to fair skin, actually had the highest skin cancer risk among a group of Caucasian women, Dr. Jiali Han of Harvard Medical School in Boston and colleagues found.

Potential New Target For Leukemia Treatment


Cincinnati Children's Hospital Medical Center has announced the publication of pioneering research identifying the crucial role and novel mechanism of action of the protein RhoH GTPase in the development and activation of cells critical to the immune system. The findings, along with other studies, suggest that RhoH GTPase may provide a target for therapeutic intervention in some types of leukemia. The paper is due to appear in an upcoming edition of the journal Nature Immunology and was recently posted in the advance online publication section of the journal's website.

New cancer drug approved for cutaneous T-cell lymphoma


by Kristina Collins, 8 Oct 2006

Lymphomas are cancers of the lymphatic system. There are two general types of lymphomas. Hodgkin's Disease, named after Dr. Thomas Hodgkin who first recognized the disease in 1832, and Non-Hodgkin's Disease (NHL). The difference between these two cancers is that Hodgkin's disease contains specific cells that are not seen in any other lymphomas. Non-Hodgkin's lymphoma is actually a group of about ten different types. One rare type of NHL is called cutaneous T-cell lymphoma (CTCL).

CTCL accounts for about one in twenty cases of NHL. It mainly affects the skin and can often mimic several skin disorders. It is caused by the uncontrolled growth of a type of white blood cell in the skin called a T-cell.

About this Archive

This page is a archive of entries in the Lymphoma category from October 2006.

Lymphoma: September 2006 is the previous archive.

Lymphoma: November 2006 is the next archive.

Find recent content on the main index or look in the archives to find all content.